Not Yet Recruiting NA INTERVENTIONAL 5-arm NCT07116239

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

Steady-state Pharmacokinetics and Pharmacodynamics of Edoxaban in Adults With Nephrotic Syndrome: A Non-randomized Open-label, Parallel Arm and Single-center Study

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions Hypoalbuminemia Nephrotic Syndrome

Interventions Edoxaban 60 mg Enoxaparin 40 mg

Updated 1 time since 2025 Last updated: Aug 4, 2025 Started: Sep 30, 2025 Primary completion: Feb 28, 2026 Completion: Feb 28, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07116239, this NA trial focuses on Hypoalbuminemia and Nephrotic Syndrome and remains actively recruiting participants. Sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese Academy of Medical Sciences, Fuwai Hospital
Peking University People's Hospital

Data source: Peking University People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.